Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Twist Bioscience Corp
Report date October 24, 2019 · Filed November 06, 2019
Section 16 reporting ended · disclosed 2019-11-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 646,112 |
Ending reported balance
After 2019-11-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2019-10-24 · Grant · Acquired 2,780 · Balance 666,112 F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Row 2 · 2019-11-01 · Disposition to issuer · Disposed 4,363 · Balance 661,749 F2: The transactions reported on this row were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3: Represents the aggregate of sales effected on the same day at different prices. F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.81 to $24.805 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Row 3 · 2019-11-01 · Disposition to issuer · Disposed 15,637 · Balance 646,112 F2: The transactions reported on this row were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3: Represents the aggregate of sales effected on the same day at different prices. F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.82 to $25.395 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.33 · Expires 2029-10-23 | Direct | 11,910 |
Reported balance
After 2019-10-24 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-10-24 · Grant · Acquired 11,910 · Balance 11,910 F6: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2: The transactions reported on this row were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F3: Represents the aggregate of sales effected on the same day at different prices.
F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.81 to $24.805 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.82 to $25.395 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F6: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2019 Filed Nov 6, 2019 02:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | Disposition to issuerCommon Stock | 15,637 | $25.10 | $392,465.24 |
DisclosureSEC source: 0001209191-19-055411 · doc4.xml · nonDerivative · entry 3 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646,112 F2 · kind: The transactions reported on this row were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.82 to $25.395 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 01, 2019 Filed Nov 6, 2019 02:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | Disposition to issuerCommon Stock | 4,363 | $24.43 | $106,581.98 |
DisclosureSEC source: 0001209191-19-055411 · doc4.xml · nonDerivative · entry 2 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661,749 F2 · kind: The transactions reported on this row were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.81 to $24.805 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 24, 2019 Filed Nov 6, 2019 02:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 11,910 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001209191-19-055411 · doc4.xml · derivative · entry 4 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,910 Underlying: Common Stock · 11,910 shares Expires 2029-10-23 F6 · derivative.exercise_date: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date. Read SEC document |
| October 24, 2019 Filed Nov 6, 2019 02:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 2,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055411 · doc4.xml · nonDerivative · entry 1 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,112 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 100 | $24.36 | $2,436.00 |
DisclosureSEC source: 0001209191-19-052203 · doc4.xml · nonDerivative · entry 3 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663,332 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,600 | $23.79 | $180,788.04 |
DisclosureSEC source: 0001209191-19-052203 · doc4.xml · nonDerivative · entry 2 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663,432 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.34 to $24.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 12,300 | $22.71 | $279,366.21 |
DisclosureSEC source: 0001209191-19-052203 · doc4.xml · nonDerivative · entry 1 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,032 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.34 to $23.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 19,153 | $30.06 | $575,685.55 |
DisclosureSEC source: 0001209191-19-049887 · doc4.xml · nonDerivative · entry 2 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,332 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.00 to $30.305 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 400 | $30.00 | $12,000.00 |
DisclosureSEC source: 0001209191-19-049887 · doc4.xml · nonDerivative · entry 1 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 702,485 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 22:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,454 | $29.82 | $73,167.48 |
DisclosureSEC source: 0001209191-19-048633 · doc4.xml · nonDerivative · entry 3 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 702,885 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $29.48 to $30.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 22:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,500 | $28.88 | $187,740.80 |
DisclosureSEC source: 0001209191-19-048633 · doc4.xml · nonDerivative · entry 2 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705,339 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.47 to $29.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 22:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,493 | $27.87 | $320,301.86 |
DisclosureSEC source: 0001209191-19-048633 · doc4.xml · nonDerivative · entry 1 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 711,839 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $27.41 to $28.375 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 22:45 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 35,004 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001209191-18-059801 · doc4.xml · derivative · entry 2 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,004 Underlying: Common Stock · 35,004 shares Expires 2028-11-18 F2 · derivative.exercise_date: 12/60th of the shares subject to the option vest and become exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 22:45 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 15,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-059801 · doc4.xml · nonDerivative · entry 1 Peck Bill · CIK 0001756137 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723,332 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 12/60th of the shares subject to the RSU Award vesting on November 20, 2019 and 1/20th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.